{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:23:46Z","timestamp":1793258626856,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.leukres.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T18:21:50Z","timestamp":1518027710000},"page":"56-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome"],"prefix":"10.1016","volume":"67","author":[{"given":"Yuta","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bungo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maasa","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kabasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Ariizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.02.004_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"87","article-title":"Myelodysplastic syndromes\/neoplasms","author":"Brunning","year":"2008"},{"key":"10.1016\/j.leukres.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2011.044602","article-title":"Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)","volume":"96","author":"Malcovati","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"201","key":"10.1016\/j.leukres.2018.02.004_bib0025","first-page":"1335","article-title":"Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis","volume":"35","author":"Rauw","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0736-4679(91)90592-4","article-title":"The red blood cell distribution width","volume":"9","author":"Evans","year":"1991","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.leukres.2018.02.004_bib0050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.leukres.2009.02.010","article-title":"Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows","volume":"33","author":"Buckstein","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.leukres.2011.05.001","article-title":"Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis","volume":"35","author":"Rauw","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ajh.23643","article-title":"Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters","volume":"89","author":"Raess","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/leu.2016.91","article-title":"Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.004_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/asheducation-2014.1.71","article-title":"Biology of BM failure syndromes: role of microenvironment and niches","volume":"2014","author":"Balderman","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.leukres.2018.02.004_bib0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/leu.2014.325","article-title":"Myelodysplasia is in the niche: novel concepts and emerging therapies","volume":"29","author":"Bulycheva","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.004_bib0080","doi-asserted-by":"crossref","first-page":"16114","DOI":"10.1038\/ncomms16114","article-title":"Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells","volume":"8","author":"Muto","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2018.02.004_bib0085","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2018.02.004_bib0090","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1182\/blood-2012-03-415356","article-title":"Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts","volume":"119","author":"Patnaik","year":"2012","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618300328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618300328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T21:27:57Z","timestamp":1603834077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618300328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":18,"alternative-id":["S0145212618300328"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.02.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}